Who owns Hornet Therapeutics?

Hornet Therapeutics is currently owned by 4Bio Partners, through 4BIO Ventures III, since 2024.

When did 4Bio Partners acquire Hornet Therapeutics?

4Bio Partners acquired Hornet Therapeutics in 2024 (active for 2 years).

Home/Companies/Biotech/Hornet Therapeutics

Hornet Therapeutics

Biotech·

UK·Active·2yr hold

Hornet Therapeutics is a biotech company, headquartered in UK.

Entry

2024

Hold

2yr

Status

Active

Est. EV

–

Investor

4Bio Partners

Key facts

HQUK

SectorBiotech

StatusActive

Biotechnology company founded by 4BIO Capital in 2024 to develop treatments for Epstein-Barr virus driven disease.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from 4BIO Ventures III

Other portfolio companies in the same fund.

Cytospire Therapeutics

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated May 2026 · Sourced from public filings